Overcoming tumor resistance by heterologous adeno-poxvirus combination therapy

Successful cancer control relies on overcoming resistance to cell death and on activation of host antitumor immunity. Oncolytic viruses are particularly attractive in this regard, as they lyse infected tumor cells and trigger robust immune responses during the infection. However, repeated injections...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Mol Ther Oncolytics
Asıl Yazarlar: Vähä-Koskela, Markus, Tähtinen, Siri, Grönberg-Vähä-Koskela, Susanna, Taipale, Kristian, Saha, Dipongkor, Merisalo-Soikkeli, Maiju, Ahonen, Marko, Rouvinen-Lagerström, Noora, Hirvinen, Mari, Veckman, Ville, Matikainen, Sampsa, Zhao, Fang, Pakarinen, Päivi, Salo, Jarmo, Kanerva, Anna, Cerullo, Vincenzo, Hemminki, Akseli
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group 2015
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4782942/
https://ncbi.nlm.nih.gov/pubmed/27119097
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mto.2014.6
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller